Innovations In Clinical Neuroscience

SEP-OCT 2014

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: http://innovationscns.epubxp.com/i/425963

Contents of this Issue

Navigation

Page 59 of 201

Innovations in CLINICAL NEUROSCIENCE [ V O L U M E 1 1 , N U M B E R 9 – 1 0 , S E P T E M B E R – O C T O B E R 2 0 1 4 ] 60 TABLE 3. Possible combinations of suicidal ideation and missing combinations in FDA-CASA 2012 titles and definitions P ossible C ombination Number P assive Ideation A ctive Ideation M ethod I ntent P lan W hich FDA-CASA 2 012 Category Title (1–5) Captures This Combination? Which FDA-CASA 2 012 Category D efinition (1–5) Captures This C ombination? C ombinations Not C aptured by FDA- CASA 2012 Titles C ombinations Not C aptured by FDA- CASA 2012 Definitions Do the FDA-CASA 2 012 Title and D efinition Both Capture This C ombination? 1 0 0 0 0 0 0 0 Yes 2 0 1 0 0 0 2 2 Y es 3 0 0 0 1 0 3 3 O verlooked 4 0 1 0 1 0 4 3 N o 5 0 0 1 0 0 3 3 Overlooked 6 0 1 1 0 0 3 3 Y es 7 0 0 1 1 0 3 3 O verlooked 8 0 1 1 1 0 4 3 No 9 0 0 0 0 1 3 3 Overlooked 10 0 1 0 0 1 3 3 Overlooked 11 0 0 0 1 1 3 3 Overlooked 12 0 1 0 1 1 5 3 No 13 0 0 1 0 1 3 3 Overlooked 14 0 1 1 0 1 3 3 Overlooked 15 0 0 1 1 1 3 3 Overlooked 16 0 1 1 1 1 5 3 No 17 1 0 0 0 0 1 1 Yes 18 1 1 0 0 0 3 3 Overlooked 19 1 0 0 1 0 3 3 Overlooked 20 1 1 0 1 0 3 3 Overlooked 21 1 0 1 0 0 3 3 Overlooked 22 1 1 1 0 0 3 3 Overlooked 23 1 0 1 1 0 3 3 Overlooked 24 1 1 1 1 0 3 3 Overlooked 25 1 0 0 0 1 3 3 Overlooked 26 1 1 0 0 1 3 3 Overlooked 27 1 0 0 1 1 3 3 Overlooked 28 1 1 0 1 1 3 3 Overlooked 29 1 0 1 0 1 3 3 Overlooked 30 1 1 1 0 1 3 3 Overlooked 31 1 0 1 1 1 3 3 Overlooked 32 1 1 1 1 1 3 3 Overlooked Total 32 6 6 26 26 Yes: 4/32; No: 4/32; Overlooked: 24/32 FDA-CASA 2012: United States Food and Drug Administration-Classification Algorithm for Suicide Assessment

Articles in this issue

Archives of this issue

view archives of Innovations In Clinical Neuroscience - SEP-OCT 2014